奥美拉唑 (Chinese Wikipedia)

Analysis of information sources in references of the Wikipedia article "奥美拉唑" in Chinese language version.

refsWebsite

Global rank Chinese rank

13web.archive.org

1^st place

5doi.org

2^nd place

23^rd place

2nih.gov

4^th place

5^th place

1drugs.com

399^th place

208^th place

1astrazeneca-us.com

low place

1medscape.com

719^th place

889^th place

1google.ca

838^th place

259^th place

1who.int

195^th place

179^th place

1msh.org

low place

2,351^st place

1thebody.com

low place

1fda.gov

447^th place

581^st place

1rxlist.com

7,927^th place

5,088^th place

1ccjm.org

low place

1cmaj.ca

low place

1ox.ac.uk

613^th place

708^th place

1archive.today

14^th place

18^th place

1udn.com

392^nd place

10^th place

archive.today

"Proton pump inhibitors and Clostridium difficile" Archive.is的存檔，存档日期2012-12-23，Bandolier. 2003. Retrieved 2007-07-13.。

astrazeneca-us.com

www1.astrazeneca-us.com

Prilosec Prescribing Information （页面存档备份，存于互联网档案馆）. AstraZeneca Pharmaceuticals.

ccjm.org

Madanick RD (Jan 2011). "Proton pump inhibitor side effects and drug interactions: much ado about nothing?". Cleve Clin J Med 78 (1): 39–49.10.3949/ccjm.77a.10087 （页面存档备份，存于互联网档案馆）。

cmaj.ca

Targownik LE, Lix LM, Metge CJ, Prior HJ, Leung S, Leslie WD (August 2008)."Use of proton pump inhibitors and risk of osteoporosis-related fractures" （页面存档备份，存于互联网档案馆），179 (4): 319–326。

doi.org

dx.doi.org

Yang YX, Lewis JD, Epstein S, Metz DC (2006). "Long-term proton pump inhibitor therapy and risk of hip fracture". JAMA 296 (24): 2947–2953.10.1001/jama.296.24.2947 （页面存档备份，存于互联网档案馆）
Stedman CA, Barclay ML (August 2000). "Review article: comparison of the pharmacokinetics, acid suppression and efficacy of proton pump inhibitors". Aliment Pharmacol Ther 14 (8): 963–978.1046/j.1365-2036.2000.00788.x
Norgard NB, Mathews KD, Wall GC (July 2009). "Drug-drug interaction between clopidogrel and the proton pump inhibitors". Ann Pharmacother 43 (7): 1266–1274.10.1503/cmaj.090251
Izzo, AA; Ernst, E (2009). "Interactions between herbal medicines and prescribed drugs: an updated systematic review". Drugs 69 (13): 1777–1798.10.2165/11317010-000000000-00000

doi.org

Vaz-Da-Silva, M; Loureiro, AI; Nunes, T; Maia, J; Tavares, S; Falcão, A; Silveira, P; Almeida, L; Soares-Da-Silva, P. Bioavailability and bioequivalence of two enteric-coated formulations of omeprazole in fasting and fed conditions. Clinical Drug Investigation. 2005, 25 (6): 391–9 [2016-09-19]. PMID 17532679. doi:10.2165/00044011-200525060-00004. （原始内容存档于2013-03-13）.

drugs.com

Omeprazole. The American Society of Health-System Pharmacists. [Dec 1, 2015]. （原始内容存档于2015-09-24）.

fda.gov

OMEPRAZOLE Label （页面存档备份，存于互联网档案馆），FDA/Center for Drug Evaluation and Research

google.ca

books.google.ca

Fischer, edited by János; Ganellin, C. Robin. Analogue-based drug discovery. Weinheim: Wiley-VCH. 2006: 88 [2017-03-07]. ISBN 9783527607495. （原始内容存档于2016-03-05）.

medscape.com

Vaz-Da-Silva, M; Loureiro, AI; Nunes, T; Maia, J; Tavares, S; Falcão, A; Silveira, P; Almeida, L; Soares-Da-Silva, P. Bioavailability and bioequivalence of two enteric-coated formulations of omeprazole in fasting and fed conditions. Clinical Drug Investigation. 2005, 25 (6): 391–9 [2016-09-19]. PMID 17532679. doi:10.2165/00044011-200525060-00004. （原始内容存档于2013-03-13）.

msh.org

erc.msh.org

Omeprazole. International Drug Price Indicator Guide. [1 December 2015]. （原始内容存档于2017年5月10日）.

nih.gov

ncbi.nlm.nih.gov

Vaz-Da-Silva, M; Loureiro, AI; Nunes, T; Maia, J; Tavares, S; Falcão, A; Silveira, P; Almeida, L; Soares-Da-Silva, P. Bioavailability and bioequivalence of two enteric-coated formulations of omeprazole in fasting and fed conditions. Clinical Drug Investigation. 2005, 25 (6): 391–9 [2016-09-19]. PMID 17532679. doi:10.2165/00044011-200525060-00004. （原始内容存档于2013-03-13）.

pubmedcentral.nih.gov

Lau WC, Gurbel PA (March 2009)."The drug-drug interaction between proton pump inhibitors and clopidogrel"，CMAJ 180 (7): 699–700.。

ox.ac.uk

medicine.ox.ac.uk

"Proton pump inhibitors and Clostridium difficile" Archive.is的存檔，存档日期2012-12-23，Bandolier. 2003. Retrieved 2007-07-13.。

rxlist.com

"Prilosec Side Effects & Drug Interactions" （页面存档备份，存于互联网档案馆），RxList.com. 2007. Retrieved 2007-06-16.。

thebody.com

Farley, D (July–August 1995)."Making it easier to read prescriptions" （页面存档备份，存于互联网档案馆），29 (6): 25–7.。

udn.com

health.udn.com

UDN-PPI會致死??. [2017-07-26]. （原始内容存档于2017-07-25）.

web.archive.org

Omeprazole. The American Society of Health-System Pharmacists. [Dec 1, 2015]. （原始内容存档于2015-09-24）.
Prilosec Prescribing Information （页面存档备份，存于互联网档案馆）. AstraZeneca Pharmaceuticals.
Vaz-Da-Silva, M; Loureiro, AI; Nunes, T; Maia, J; Tavares, S; Falcão, A; Silveira, P; Almeida, L; Soares-Da-Silva, P. Bioavailability and bioequivalence of two enteric-coated formulations of omeprazole in fasting and fed conditions. Clinical Drug Investigation. 2005, 25 (6): 391–9 [2016-09-19]. PMID 17532679. doi:10.2165/00044011-200525060-00004. （原始内容存档于2013-03-13）.
Fischer, edited by János; Ganellin, C. Robin. Analogue-based drug discovery. Weinheim: Wiley-VCH. 2006: 88 [2017-03-07]. ISBN 9783527607495. （原始内容存档于2016-03-05）.
WHO Model List of EssentialMedicines (PDF). World Health Organization. October 2013 [22 April 2014]. （原始内容存档 (PDF)于2016-04-11）.
Omeprazole. International Drug Price Indicator Guide. [1 December 2015]. （原始内容存档于2017年5月10日）.
Farley, D (July–August 1995)."Making it easier to read prescriptions" （页面存档备份，存于互联网档案馆），29 (6): 25–7.。
OMEPRAZOLE Label （页面存档备份，存于互联网档案馆），FDA/Center for Drug Evaluation and Research
"Prilosec Side Effects & Drug Interactions" （页面存档备份，存于互联网档案馆），RxList.com. 2007. Retrieved 2007-06-16.。
Madanick RD (Jan 2011). "Proton pump inhibitor side effects and drug interactions: much ado about nothing?". Cleve Clin J Med 78 (1): 39–49.10.3949/ccjm.77a.10087 （页面存档备份，存于互联网档案馆）。
Yang YX, Lewis JD, Epstein S, Metz DC (2006). "Long-term proton pump inhibitor therapy and risk of hip fracture". JAMA 296 (24): 2947–2953.10.1001/jama.296.24.2947 （页面存档备份，存于互联网档案馆）
Targownik LE, Lix LM, Metge CJ, Prior HJ, Leung S, Leslie WD (August 2008)."Use of proton pump inhibitors and risk of osteoporosis-related fractures" （页面存档备份，存于互联网档案馆），179 (4): 319–326。
UDN-PPI會致死??. [2017-07-26]. （原始内容存档于2017-07-25）.

who.int

apps.who.int

WHO Model List of EssentialMedicines (PDF). World Health Organization. October 2013 [22 April 2014]. （原始内容存档 (PDF)于2016-04-11）.